Company · CIK 0001128495
ANADYS PHARMACEUTICALS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AANADYS PHARMACEUTICALS INC0001172661-12-000251 · 11.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-11-325909 · 20.1 KBSEC(opens sec.gov)
- SC 13G/AANADYS PHARMACEUTICALS INC0001318148-11-002058 · 136.0 KBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-11-299984 · 1.7 MBSEC(opens sec.gov)
- 8-KCurrent report0001299933-11-003253 · 54.8 KBSEC(opens sec.gov)
- SC 13D/AANADYS PHARMACEUTICALS INC0001193125-11-297502 · 102.0 KBSEC(opens sec.gov)
- SC 13D/AANADYS PHARMACEUTICALS INC0001193125-11-287409 · 102.0 KBSEC(opens sec.gov)
- SC 13DANADYS PHARMACEUTICALS INC0001193125-11-280767 · 133.1 KBSEC(opens sec.gov)
- SC 13D/AANADYS PHARMACEUTICALS INC0000950123-11-091663 · 89.6 KBSEC(opens sec.gov)
- 4Insider trades0001209191-11-052489 · 8.5 KBSEC(opens sec.gov)
Insiders
- Appleman James R.SVP, Research & CSO
- AVERETT DEVRON RChief Scientific Officer
- Eastwood Kevin L.SVP, Corporate Development
- FISHERMAN JASON SDirector
- FOLETTA MARK GDirector
- FOTIADIS MARIOSDirector
- Freddo James LDirector, SVP, Drug Development and CMO
- Gallagher Carol GiltnerVP, Corp. Dev. & Comm. Affairs
- GLOVER JAMES TSVP, Operations and CFO
- HBM BIOVENTURES AG10% Owner
Tickers
No tickers on record.
Addresses
business
5871 OBERLIN DRIVE, SUITE 200
SAN DIEGO, CA, 92121
mailing
5871 OBERLIN DRIVE, SUITE 200
SAN DIEGO, CA, 92121
Same industry